PointState Capital’s Elanco Animal Health ELAN Stock Holding History

PointState Capital’s Portfolio ELAN Stock Details ELAN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-200,000	Closed	-$5.68M	–	89
2021 Q4	$5.68M	Sell	200,000 -77,300	-28%	-$2.4M	0.09%	81
2021 Q3	$8.84M	Sell	277,300 -3,000	-1%	-$101K	0.15%	88
2021 Q2	$9.72M	Sell	280,300 -11,200	-4%	-$369K	0.17%	78
2021 Q1	$8.59M	Sell	291,500 -40,386	-12%	-$1.24M	0.17%	83
2020 Q4	$10.2M	Buy	331,886 +276,886	+503%	+$8.45M	0.19%	73
2020 Q3	$1.54M	Sell	55,000 -7,700	-12%	-$195K	0.04%	87
2020 Q2	$1.34M	Buy	+62,700	New	+$1.38M	0.04%	79
2019 Q4	–	Sell	-44,400	Closed	-$1.18M	–	117
2019 Q3	$1.18M	Buy	+44,400	New	+$1.33M	0.03%	92
2019 Q2	–	Sell	-63,004	Closed	-$2.02M	–	125
2019 Q1	$2.02M	Buy	+63,004	New	+$1.94M	0.04%	96

Other funds holding ELAN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Aristotle Capital Management Los Angeles, California $47.7B AUM 13.92% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

SHCM

Sachem Head Capital Management New York $4.82B AUM 73.38% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Amundi Paris, France $416B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

PointState Capital's ELAN Position: Q1 2022 in Review

PointState Capital sold out of Elanco Animal Health (ELAN) in Q1 2022, closing a stake of 200,000 shares — an estimated $5.68M sold.

PointState Capital first reported a position in ELAN in Q1 2019 and held it in 9 quarters. The position peaked at $10.2M in Q4 2020. 472 funds tracked by Wall St. Rank hold ELAN as of Q1 2022.

PointState Capital reported no remaining Elanco Animal Health position as of Q1 2022 after selling out during the quarter.
PointState Capital sold 200,000 Elanco Animal Health shares in Q1 2022, an estimated $5.68M.
PointState Capital first reported a position in Elanco Animal Health in Q1 2019 and held it in 9 quarters.
PointState Capital's Elanco Animal Health position peaked at $10.2M in Q4 2020.
472 funds tracked by Wall St. Rank held Elanco Animal Health as of Q1 2022.

Based on PointState Capital's 13F filing for Q1 2022, filed 13 May 2022.